www.trustedtabs.org

Your reliable supplier of generic medications.

Check yourbonu$
Site search:
Obvious advantage Tell a friend and get discount! Want to give it a try?
Categories list

Generic Bicalutamide - Casodex

Search by letter:ABCDEFGHIJKLMNOPQRSTUVWXYZ
Casodex

Generic Casodex

Bicalutamide 50mg

Generic Casodex is used for treating prostate cancer.This medicine is intended for use with other medicines.
More info »

€ 3.70 Buy now!
Country, language and currency
Social bookmarks:
Testimonials

I appreciate your personalized customer service and prompt follow up. All I can say is this, if you are this straight forward and direct when something goes wrong, then you treat your customers with respect. And if you do that on a regular basis, you deserve to have great things happen to you in the future.
I will be in touch.
Thanks.

Our billing is certified by:

Secure shopping certificates


Special Offer!

News

  • Medivation Files Enzalutamide NDA - Zacks.com

    Medivation Files Enzalutamide NDAZacks.

  • Medivation Reports First Quarter Financial Results and Provides Corporate Update - MarketWatch (press release)

    Medivation Reports First Quarter Financial Results and Provides Corporate UpdateMarketWatch (press release)Continued to enroll patients in the Phase 2 TERRAIN trial, which is comparing the effect of enzalutamide versus bicalutamide, the most commonly used anti-androgen, on progression-free survival in approximately 370 men with advanced prostate cancer who .

  • MDVN Misses; Focus on Enzalutamide - Zacks.com

    MDVN Misses; Focus on EnzalutamideZacks.

  • MDVN Misses; Focus on Enzalutamide - Analyst Blog - NASDAQ

    MDVN Misses; Focus on Enzalutamide - Analyst BlogNASDAQEnzalutamide is also in a phase II study (TERRAIN), which will compare enzalutamide with bicalutamide, in advanced prostate cancer patients who have progressed following medical castration with LHRH analog therapy or surgical castration.

  • New Therapies for Prostate Cancer: The Practicalities - OncLive

    OncLiveNew Therapies for Prostate Cancer: The PracticalitiesOncLive12,13 This investigational agent is an irreversible androgen receptor (AR) antagonist and AR signaling inhibitor, and represents an advance from the nonsteroidal AR antagonists flutamide, bicalutamide, and nilutamide.

bookmark Bookmark this site
Subscribe to the News
Trusted. Rx approved.